We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+25.17%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$14.8B
AUM Growth
+$1.58B
Cap. Flow
-$1.22B
Cap. Flow %
-8.22%
Top 10 Hldgs %
44.34%
Holding
132
New
32
Increased
38
Reduced
29
Closed
16

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$317M
2
CRM icon
Salesforce
CRM
+$270M
3
TMO icon
Thermo Fisher Scientific
TMO
+$259M
4
MDCO
Medicines Co
MDCO
+$221M
5
PPLI
People Inc
PPLI
+$137M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.55B
2
BRMK
Broadmark Realty Capital Inc. Common Stock
BRMK
+$754M
3
AABA
Altaba Inc
AABA
+$666M
4
BABA icon
Alibaba
BABA
+$196M
5
CTXS
Citrix Systems Inc
CTXS
+$183M

Sector Composition

Rank Sector Weight
1 Healthcare 38.48%
2 Communication Services 11.12%
3 Technology 9.77%
4 Industrials 5.05%
5 Financials 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARWR icon
101
Arrowhead Research
ARWR
$12.1B
$6.34M 0.04%
100,000
-550,000
-85% -$27.3M
PHAS
102
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$6.11M 0.04%
1,000,000
+192,072
+24% +$791K
OYST
103
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$5.64M 0.04%
+230,800
New +$4.05M
ATRA icon
104
Atara Biotherapeutics
ATRA
$74.3M
$5.51M 0.04%
+13,388
New +$4.62M
XRX icon
105
Xerox
XRX
$424M
$4.79M 0.03%
+130,000
New +$4.55M
OPK icon
106
Opko Health
OPK
$985M
$3.67M 0.02%
+2,500,000
New +$4.19M
BRMK.WS
107
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$2.73M 0.02%
+7,174,613
New +$2.19M
LRMR icon
108
Larimar Therapeutics
LRMR
$436M
$2.01M 0.01%
150,697
– –
APTX
109
DELISTED
Aptinyx Inc. Common Stock
APTX
$1.4M 0.01%
408,549
-265,592
-39% -$915K
CYCN icon
110
Cyclerion Therapeutics
CYCN
$16.7M
$952K 0.01%
17,500
-1,331
-7% -$124K
ACAD icon
111
Acadia Pharmaceuticals
ACAD
$4.9B
– –
-350,000
Closed -$12.6M
AZN icon
112
AstraZeneca
AZN
$250B
– –
-1,187,893
Closed -$106M
BKNG icon
113
Booking.com
BKNG
$156B
– –
-778,475
Closed -$61.1M
COHR icon
114
Coherent
COHR
$65.4B
– –
-47,687
Closed -$1.68M
NXPI icon
115
NXP Semiconductors
NXPI
$58.4B
– –
-325,000
Closed -$35.5M
SE icon
116
Sea Limited
SE
$68B
– –
-3,375,000
Closed -$104M
UBER icon
117
PUT
Uber
UBER
$143B
– –
-1,102,500
Closed -$33.6M
CTXS
118
DELISTED
Citrix Systems Inc
CTXS
– –
-1,900,323
Closed -$183M
PFNX
119
DELISTED
Pfenex Inc.
PFNX
– –
-600,000
Closed -$5.06M
GWR
120
DELISTED
Genesee & Wyoming Inc.
GWR
– –
-782,673
Closed -$86.5M
PVTL
121
DELISTED
Pivotal Software, Inc.
PVTL
– –
-1,430,000
Closed -$21.3M
ONCE
122
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-220,000
Closed -$21.3M
BPL
123
DELISTED
Buckeye Partners, L.P.
BPL
– –
-3,900,000
Closed -$160M
ALDR
124
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-4,165,000
Closed -$78.6M
AABA
125
DELISTED
Altaba Inc
AABA
– –
-34,189,499
Closed -$666M
2 3 4
5
6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Farallon Capital Management held 132 positions worth $14.8B, up 12% from $13.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Farallon Capital Management withdrew a net $1.22B in Q4 2019, closing 16 positions and reducing 29 holdings. Its most notable exit was Celgene Corp, an estimated $1.55B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 40% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Farallon Capital Management opened a new position in Salesforce worth $281M.

  • Farallon Capital Management's largest Q4 2019 buy was Salesforce: 1,724,880 shares worth $281M.
  • Farallon Capital Management added most to Allergan plc in Q4 2019, an estimated $317M increase.
  • Farallon Capital Management's biggest Q4 2019 reduction was Broadmark Realty Capital Inc. Common Stock, cutting an estimated $754M.
  • Farallon Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.55B.
  • Farallon Capital Management's ten largest holdings make up 44% of its $14.8B portfolio in Q4 2019.
  • Farallon Capital Management opened 32 new positions and closed 16 in Q4 2019.
  • Farallon Capital Management's portfolio value rose 12% quarter-over-quarter to $14.8B.

Based on Farallon Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.